Patients with known DM prior to treatment initiation were managed by lifestyle modifications only in three patients (3%), while the remaining 97 (97%) patients were prescribed anti-diabetes medications, including 45 (45%) patients receiving insulin with or without other oral hypoglycemic agents, and 41 (41%) patients prescribed a metformin-based oral therapy. This evidence concerns the gene INS and diabetes mellitus.